Female

Manufacturer
VIATREXX BIO INCORPORATED | Les Importations Herbasante Inc
Effective date
2022-11-30
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:18:45

Label at a glance#

ProductFemale
Active ingredientBOS TAURUS ADRENAL GLAND, SUS SCROFA ADRENAL GLAND, CHOLESTEROL, SUS SCROFA CORPUS LUTEUM, ESTROGENS, ESTERIFIED, BOS TAURUS HYPOTHALAMUS, SUS SCROFA HYPOTHALAMUS, MELATONIN, BOS TAURUS OVARY, SUS SCROFA OVARY, BOS TAURUS PANCREAS, SUS SCROFA PANCREAS, BOS TAURUS PINEAL GLAND, SUS SCROFA PINEAL GLAND, BOS TAURUS PITUITARY GLAND, SUS SCROFA PITUITARY GLAND, PROGESTERONE, SUS SCROFA THALAMUS, BOS TAURUS THYMUS, SUS SCROFA THYMUS, THYROID, BOVINE, THYROID, PORCINE
Label structure10 sections

Indications and uses

To help support the structure & function of the female endocrine system

Storage and handling

Normal storage use. Do not use if tamper-evident seal is broken or removed.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Adrenal gland 6X 200K, Cholesterinum 6X 200K, Corpus luteum 6X 200K, Estrogen 6X 200K, Hypothalamus 6X 200K, Melatonin 6X 200K, Ovary 6X 200K, Pancreas 6X 200K, Pineal gland 6X 200K, Pituitary 6X 200K, Progesterone 6X 200K, Thalamus Gland 6X 200K, Thymus gland 6X 200K, Thyroid gland 6X 200K

Purpose

OTC - PURPOSE SECTION

Adrenal glandAdrenal support
CholesterinumDrainage
Corpus luteumRegeneration
EstrogenHormonal support
HypothalamusRegeneration
MelatoninNeurological support
OvaryRegeneration
PancreasRegeneration
Pineal glandRegeneration
PituitaryRegeneration
ProgesteroneHormonal support
Thalamus GlandRegeneration
Thymus glandRegeneration
Thyroid glandRegeneration

Uses

INDICATIONS & USAGE SECTION

To help support the structure & function of the female endocrine system

Warnings

WARNINGS SECTION

Stop use and ask a health care practitioner if symptoms persist for more than 5 days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.

Dosage

DOSAGE & ADMINISTRATION SECTION

1-3 spray(s); 1-3 time(s) per day or as recommended by your healthcare practitioner.

 

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children.

Other Ingredients

INACTIVE INGREDIENT SECTION

Alcohol and Water

Other Information

STORAGE AND HANDLING SECTION

Normal storage use.

Do not use if tamper-evident seal is broken or removed.

Questions

OTC - QUESTIONS SECTION

info@viatrexx.com

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ITEM: VPC0187

NDC 63776-171-15

Homeopathic remedy

Female +

• To help support the structure & function of the female endocrine system

Oral spray
50ml 1.7 oz

Viatrexx™ Bio Incorporated

Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Female + Box
Female + Box

Female +

50 mL
1.7 oz

Viatrexx™ Bio Incorporated

ITEM: VPC0187
NDC: 63776-171-15 

INDICATIONS:
To help support the structure & function of the female endocrine system

DIRECTIONS:
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.

Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

Ingredients
Ingredients

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b46148e2-ee15-98d5-12f0-f5ec8745f6fcProduct name320220927
76820076-f087-4073-b1d1-aa04b361335eProduct name220220921
d3229c1a-4e51-4e04-9b13-00d24fd35242Product name120200821
213f0591-95c1-b398-40b7-08b31f66b026Product name420190206
85b2d644-53b2-f2dc-4dbc-859116ce56c0Product name120140508
aaaf3f1f-0ca7-2c75-a463-4dc624538feeProduct name120140508
d048f0e3-3c40-8816-8c5c-0ca5cd189aacProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63776-171-152024-01-30C16284748780-19d75b9cf-e597-f424-e053-dadaa90a57ceFemale +
63776-171-152022-01-14C16284748780-19d75b9cf-e597-f424-e053-dadaa90a57ceFemale +
63776-171-152020-01-31C16284748780-19d75b9cf-e597-f424-e053-dadaa90a57ceFemale +

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63776-171-15Female1 in 1 BOXSPRAY14
63776-171-15Female50 mL in 1 BOTTLE, SPRAYSPRAY504

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63776-171FEMALE (BOS TAURUS ADRENAL GLAND, SUS SCROFA ADRENAL GLAND, CHOLESTEROL, SUS SCROFA CORPUS LUTEUM, ESTERIFIED ESTROGEN, BOS TAURUS HYPOTHALAMUS, SUS SCROFA HYPOTHALAMUS, MELATONIN, BOS TAURUS OVARY, SUS SCROFA OVARY, BOS TAURUS PANCREAS, SUS SCROFA PANCREAS, BOS TAURUS PINEAL GLAND, SUS SCROFA PINEAL GLAND, BOS TAURUS PITUITARY GLAND, SUS SCROFA PITUITARY GLAND, PROGESTERONE, SUS SCROFA THALAMUS, BOS TAURUS THYMUS, SUS SCROFA THYMUS, THYROID BOVINE, THYROID PORCINE) SPRAY [VIATREXX BIO INCORPORATED]4Legacy NDC, 2 package rows20221202_fd72d28a-21db-454a-9f0a-cb081521a7a9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63776-17163776-171-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
eeb56bb9-95be-56dd-e053-2995a90a328afd72d28a-21db-454a-9f0a-cb081521a7a92022-11-30WarningsExact identifier
spl id: eeb56bb9-95be-56dd-e053-2995a90a328a
spl set id: fd72d28a-21db-454a-9f0a-cb081521a7a9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.